Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.8M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
24.2M
-
Shares change
-
-79.8K
-
Total reported value, excl. options
-
$552M
-
Value change
-
+$1.46M
-
Put/Call ratio
-
2.18
-
Number of buys
-
31
-
Number of sells
-
-20
-
Price
-
$22.87
Significant Holders of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) as of Q4 2021
67 filings reported holding FHTX - Foghorn Therapeutics Inc. - COMMON STOCK as of Q4 2021.
Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.2M shares
of 55.8M outstanding shares and own 43.3% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (2.48M shares), Artal Group S.A. (1.72M shares), Euclidean Capital LLC (1.26M shares), BlackRock Inc. (1.15M shares), VANGUARD GROUP INC (845K shares), MORGAN STANLEY (552K shares), Alphabet Inc. (501K shares), Point72 Asset Management, L.P. (383K shares), and GEODE CAPITAL MANAGEMENT, LLC (347K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.